Functional and molecular evaluation of lymphocytes

被引:22
作者
Fleisher, TA [1 ]
Oliveira, JB [1 ]
机构
[1] NIH, Serv Immunol, Dept Lab Med, Ctr Clin,Dept Hlth & Human Serv, Bethesda, MD USA
关键词
lymphocytes; immune deficiency; diagnostic immunology;
D O I
10.1016/j.jaci.2004.06.001
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The laboratory plays a central role in the evaluation of immune function and is critical in the diagnosis and treatment of immune deficiencies. The range of options available to evaluate lymphocyte function has expanded dramatically as our understanding of the immune system has expanded. As the choices of laboratory tests increase, so also does the need to choose testing in such a way as to appropriately direct the evaluation. Typically, this approach involves starting with screening tests and, on the basis of the results of these tests, deciding whether more sophisticated and expensive testing is warranted. The remarkable developments over the past decade leading to the identification of numerous gene defects underlying a variety of immune deficiencies has moved mutation analysis into the realm of the clinical laboratory. This information could be indispensable for immune deficiency diagnosis, prenatal screening, carrier detection, and family counseling. In this review a sequential approach to evaluating lymphocyte function is presented, starting with readily available screening tests and followed by more complex in vitro testing, including the application of newer assays. The various approaches are presented from the perspective of appropriate use and information garnered, whereas actual details of test procedures are not discussed but are referenced. The evolution of immune function testing suggests that it will continue to develop, and future assays are likely to provide even more insight into specific aspects of the immune response and be linked to immune deficiencies not yet defined.
引用
收藏
页码:227 / 234
页数:8
相关论文
共 74 条
  • [1] CD27: a memory B-cell marker
    Agematsu, K
    Hokibara, S
    Nagumo, H
    Komiyama, A
    [J]. IMMUNOLOGY TODAY, 2000, 21 (05): : 204 - 206
  • [2] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [3] Variables that affect assays for plasma cytokines and soluble activation markers
    Aziz, N
    Nishanian, P
    Mitsuyasu, R
    Detels, R
    Fahey, JL
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (01) : 89 - 95
  • [4] NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals
    Bakker, ABH
    Wu, J
    Phillips, JH
    Lanier, LL
    [J]. HUMAN IMMUNOLOGY, 2000, 61 (01) : 18 - 27
  • [5] Primary immunodeficiency disorders: Antibody deficiency
    Ballow, M
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (04) : 581 - 591
  • [6] Measurement and interpretation of pneumococcal IgG levels for clinical management
    Balmer, P
    North, J
    Baxter, D
    Stanford, E
    Melegaro, A
    Kaczmarski, EB
    Miller, E
    Borrow, R
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (03) : 364 - 369
  • [7] IGG AND IGM PNEUMOCOCCAL POLYSACCHARIDE ANTIBODY-RESPONSES IN INFANTS
    BARRETT, DJ
    LEE, CG
    AMMANN, AJ
    AYOUB, EM
    [J]. PEDIATRIC RESEARCH, 1984, 18 (11) : 1067 - 1071
  • [8] Human natural killer cell receptors: insights into their molecular function and structure
    Biassoni, R
    Cantoni, C
    Marras, D
    Giron-Michel, J
    Falco, N
    Moretta, L
    Dimasi, N
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (04): : 376 - 387
  • [9] IgG Fc receptor polymorphisms in human disease: Implications for intravenous immunoglobulin therapy
    Binstadt, BA
    Geha, RS
    Bonilla, FA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (04) : 697 - 703
  • [10] Immunophenotyping
    Bleesing, JJH
    Fleisher, TA
    [J]. SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 100 - 110